🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines Trump’s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines Trump’s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications
Updated 04 Jul 2026 · HPRA open data

Otsuka Pharmaceutical Netherlands B.V. — Licensed Medicines

30 medicines held by Otsuka Pharmaceutical Netherlands B.V. on the Irish market, from the HPRA register of authorised products.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0–9
← All medicines · 30 products held by Otsuka Pharmaceutical Netherlands B.V.
MedicineActive substanceLicence holderStatus
Abilify 1 mg/mL oral solution
EU/1/04/276/033-035
Aripiprazole Otsuka Pharmaceutical Netherlands B.V.
Abilify 10 mg orodispersible tablets
EU/1/04/276/024-026
Aripiprazole Otsuka Pharmaceutical Netherlands B.V.
Abilify 10 mg tablets
EU/1/04/276/006-010
Aripiprazole Otsuka Pharmaceutical Netherlands B.V.
Abilify 15 mg orodispersible tablets
EU/1/04/276/027-029
Aripiprazole Otsuka Pharmaceutical Netherlands B.V.
Abilify 15 mg tablets
EU/1/04/276/011-015
Aripiprazole Otsuka Pharmaceutical Netherlands B.V.
Abilify 30 mg orodispersible tablets
EU/1/04/276/030-032
Aripiprazole Otsuka Pharmaceutical Netherlands B.V.
Abilify 30 mg tablets
EU/1/04/276/016-020
Aripiprazole Otsuka Pharmaceutical Netherlands B.V.
Abilify 5 mg tablets
EU/1/04/276/001-005
Aripiprazole Otsuka Pharmaceutical Netherlands B.V.
Abilify 7.5 mg/mL solution for injection
EU/1/04/276/036
Aripiprazole Otsuka Pharmaceutical Netherlands B.V.
Abilify Maintena 300 mg powder and solvent for prolonged-release suspension for injection
EU/1/13/882/001,003
Aripiprazole Otsuka Pharmaceutical Netherlands B.V.
Abilify Maintena 400 mg powder and solvent for prolonged-release suspension for injection
EU/1/13/882/002,004
Aripiprazole Otsuka Pharmaceutical Netherlands B.V.
Abilify Maintena 720 mg prolonged-release suspension for injection in pre-filled syringe
EU/1/13/882/009
Aripiprazole Monohydrate Otsuka Pharmaceutical Netherlands B.V.
Abilify Maintena 960 mg prolonged-release suspension for injection in pre-filled syringe
EU/1/13/882/010
Aripiprazole Monohydrate Otsuka Pharmaceutical Netherlands B.V.
Dawnzera 80mg solution for injection in pre-filled pen
EU/1/25/2001/001-002
Donidalorsen sodium Otsuka Pharmaceutical Netherlands B.V.
Inaqovi 35 mg/100 mg film-coated tablets
EU/1/23/1756/001
Decitabine, Cedazuridine Otsuka Pharmaceutical Netherlands B.V.
Jinarc 15 mg tablets
EU/1/15/1000/001-002
Tolvaptan Otsuka Pharmaceutical Netherlands B.V.
Jinarc 15 mg tablets + Jinarc 45 mg tablets
EU/1/15/1000/005-007
Tolvaptan Otsuka Pharmaceutical Netherlands B.V.
Jinarc 30 mg tablets
EU/1/15/1000/003-004
Tolvaptan Otsuka Pharmaceutical Netherlands B.V.
Jinarc 30 mg tablets + Jinarc 60 mg tablets
EU/1/15/1000/008-010
Tolvaptan Otsuka Pharmaceutical Netherlands B.V.
Jinarc 30 mg tablets + Jinarc 90 mg tablets
EU/1/15/1000/011-013
Tolvaptan Otsuka Pharmaceutical Netherlands B.V.
Lupkynis 7.9 mg soft capsules
EU/1/22/1678/001
Voclosporin Otsuka Pharmaceutical Netherlands B.V.
RXULTI 0.25 mg Film-coated tablet
EU/1/18/1294/001
Brexpiprazole Otsuka Pharmaceutical Netherlands B.V.
RXULTI 0.5 mg Film-coated tablet
EU/1/18/1294/002
Brexpiprazole Otsuka Pharmaceutical Netherlands B.V.
RXULTI 1 mg Film-coated tablet
EU/1/18/1294/003-004
Brexpiprazole Otsuka Pharmaceutical Netherlands B.V.
RXULTI 2 mg Film-coated tablet
EU/1/18/1294/005
Brexpiprazole Otsuka Pharmaceutical Netherlands B.V.
RXULTI 3 mg Film-coated tablet
EU/1/18/1294/006
Brexpiprazole Otsuka Pharmaceutical Netherlands B.V.
RXULTI 4 mg Film-coated tablet
EU/1/18/1294/007
Brexpiprazole Otsuka Pharmaceutical Netherlands B.V.
Samsca 15 mg Tablet
EU/1/09/539/1-2
Tolvaptan Otsuka Pharmaceutical Netherlands B.V.
Samsca 30 mg Tablet
EU/1/09/539/3-4
Tolvaptan Otsuka Pharmaceutical Netherlands B.V.
Samsca 7.5 mg Tablet
EU/1/09/539/005-006
Tolvaptan (opc-41061) Otsuka Pharmaceutical Netherlands B.V.
Cite this database

Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 19 August 2026).

Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.